StockData
Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc. (RPID) stock

RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3051% below fair value
$0.74+0.00 (+0.11%)

Close on Nov 18, 2026Market cap $37.00MP/E –Yield –

Rapid Micro Biosystems free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Rapid Micro Biosystems's free cash flow for the twelve months ending Jun 30, 2026 was -$40.39M. For fiscal 2025 it was -$31.91M. The highest annual figure on record is -$31.69M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$31.91M–
FY2024Dec 31, 2024-$45.52M–
FY2023Dec 31, 2023-$46.93M–
FY2022Dec 31, 2022-$65.29M–
FY2021Dec 31, 2021-$58.18M–
FY2020Dec 31, 2020-$31.69M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.48M–
Q1 FY2026Mar 31, 2026-$15.45M–
Q4 FY2025Dec 31, 2025-$3.34M–
Q3 FY2025Sep 30, 2025-$9.12M–
Q2 FY2025Jun 30, 2025-$10.07M–
Q1 FY2025Mar 31, 2025-$9.38M–
Q4 FY2024Dec 31, 2024-$10.01M–
Q3 FY2024Sep 30, 2024-$8.82M–
Q2 FY2024Jun 30, 2024-$10.58M–
Q1 FY2024Mar 31, 2024-$16.11M–
Q4 FY2023Dec 31, 2023-$9.92M–
Q3 FY2023Sep 30, 2023-$10.16M–
Q2 FY2023Jun 30, 2023-$9.41M–
Q1 FY2023Mar 31, 2023-$17.45M–
Q4 FY2022Dec 31, 2022-$12.47M–
Q3 FY2022Sep 30, 2022-$16.69M–
Q2 FY2022Jun 30, 2022-$16.98M–
Q1 FY2022Mar 31, 2022-$19.15M–
Q4 FY2021Dec 31, 2021-$14.85M–
Q3 FY2021Sep 30, 2021-$19.77M–
Q2 FY2021Jun 30, 2021-$12.05M–
Q1 FY2021Mar 31, 2021-$11.51M–
Q4 FY2020Dec 31, 2020-$5.30M–
Q3 FY2020Sep 30, 2020-$8.99M–

More Rapid Micro Biosystems figures

See a number that looks wrong?